Ingredient

Dihydrogenated Tallow Phthalic Acid Amide

Dihydrogenated Tallow Phthalic Acid Amide is flagged for pregnancy and trying to conceive. The concern behind the strongest flag is absorbed into the body.

By Team TruvaLast checked

Verdict by profile

Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.

Strongest verdict
Caution Advised
Its verdict for pregnancy, the profile this one is worst in
Profiles flagged
2 of 6
Counting avoid, high risk and medium risk
Irritancy
2 of 5
Higher means more likely to sting or redden
PregnancyCAUTION

Dihydrogenated Tallow Phthalic Acid Amide and pregnancy

Caution Advised

Dihydrogenated tallow phthalic acid amide is a synthetic compound derived from animal fat combined with phthalic acid, used as an emollient and film-former in cosmetics. While the 'phthalic acid' portion is chemically different from restricted phthalate plasticizers, the compound's safety profile during pregnancy has not been extensively studied. The main concern during pregnancy is the lack of safety data specific to this ingredient. While it is not classified as a phthalate plasticizer (which are known endocrine disruptors), the phthalic acid derivative structure and potential for skin absorption raise theoretical concerns. The tallow-based component is generally considered safe, but the modified structure has not been evaluated for pregnancy safety by major regulatory bodies. Neither ACOG nor the FDA has issued specific guidance on this ingredient during pregnancy. Given the limited data and the presence of phthalic acid derivatives in the structure, many healthcare providers recommend a precautionary approach. Pregnant women may choose to avoid products with this ingredient, particularly in leave-on formulations, until more comprehensive safety data becomes available.

BreastfeedingSAFE

Dihydrogenated Tallow Phthalic Acid Amide and breastfeeding

Safe to Use

Dihydrogenated tallow phthalic acid amide is used as an emollient in cosmetic formulations. When applied topically, it forms a protective film on the skin's surface, and absorption into the bloodstream is expected to be minimal due to its large molecular size and lipophilic nature. While specific studies on breastfeeding are lacking, the risk of transfer to breast milk is considered low for topical use. The ingredient is structurally distinct from endocrine-disrupting phthalates and is used in relatively small amounts in cosmetic products. The molecular characteristics suggest limited systemic absorption when applied to intact skin. No medical organizations have issued specific warnings about this ingredient during breastfeeding. However, given the limited safety data, some lactation consultants may recommend avoiding application near the breast area or choosing better-studied alternatives for facial and chest products.

PostpartumSAFE

Dihydrogenated Tallow Phthalic Acid Amide and postpartum

Safe to Use

Dihydrogenated tallow phthalic acid amide can be used by postpartum women not breastfeeding, though its comedogenic potential may be a concern for those experiencing postpartum hormonal acne. The ingredient's occlusive properties may help with skin barrier repair but could also clog pores in acne-prone individuals. The main considerations for postpartum use are skin type and sensitivity rather than reproductive concerns. Women with oily or acne-prone skin may want to avoid this ingredient in favor of lighter, non-comedogenic emollients.

Trying to ConceiveCAUTION

Dihydrogenated Tallow Phthalic Acid Amide and trying to conceive

Caution Advised

Dihydrogenated tallow phthalic acid amide has limited safety data for women trying to conceive. While it is not a phthalate plasticizer, the phthalic acid derivative structure and lack of reproductive toxicity studies warrant a cautious approach during the preconception period. Since pregnancy safety data is limited, women trying to conceive may choose to discontinue use of products containing this ingredient as a precautionary measure, similar to the approach taken during early pregnancy.

PCOSSAFE

Dihydrogenated Tallow Phthalic Acid Amide and PCOS

Safe to Use

Dihydrogenated tallow phthalic acid amide is a film-forming emollient derived from hydrogenated animal fat and phthalic acid. Its heavy, occlusive texture can be problematic for women with PCOS who often experience increased sebum production and acne. While there are no known hormonal interactions with PCOS, the ingredient's comedogenic potential is a concern. Women with PCOS-related acne may find that this ingredient exacerbates breakouts by clogging pores and trapping oil and bacteria in the skin. For PCOS-related skin concerns, lighter, non-comedogenic moisturizers are generally preferred. The ingredient does not affect androgen levels or insulin sensitivity but may worsen acne symptoms through mechanical pore-clogging rather than hormonal mechanisms.

General UseSAFE

Dihydrogenated Tallow Phthalic Acid Amide and general use

Safe to Use

Dihydrogenated tallow phthalic acid amide is a synthetic emollient and film-forming agent used in cosmetics to create a protective barrier on the skin. It is derived from hydrogenated animal fat combined with phthalic acid derivatives, creating a stable, occlusive ingredient. The main concerns for general use are potential comedogenicity and mild irritation in sensitive individuals. The ingredient's heavy texture may clog pores in acne-prone skin types, and some users may experience contact dermatitis. It is not associated with the same endocrine disruption concerns as phthalate plasticizers, as the chemical structure is different. The ingredient is approved for use in cosmetics but is not extensively studied compared to more common emollients. Individuals with oily or acne-prone skin may prefer lighter alternatives, while those with very dry skin may benefit from its occlusive properties.

Same profiles

Everything else flagged for the same profiles

Keep reading

Related ingredients

Ingredients suggested in place of Dihydrogenated Tallow Phthalic Acid Amide, each one with its own page here.

Ingredients that raise the same concerns.

Provenance

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on .

One ingredient is the easy case.

A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.

Download on theApp Store